David McClung is CFO at BioCardia, Inc. (BCDA). They have made 8 open-market trades across 1 company since 2018, most recently 2026-07-02.
CIK 0001686155
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $54K since 2018, never a sale. Across 8 scored buys the stock is down 6.2% at ninety days, and 7.4 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BCDA | 114,245 | $105K |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 0% | 25% |
| Avg Move | -3.0% | -5.2% | -6.2% |
| Alpha | -7.6% | -5.6% | -7.4% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCDA | BUY | 2025-06-30 | 2025-07-02 | $2.08 | $10K | +7.0% | +0.0% | -39.4% |
| BCDA | BUY | 2025-04-23 | 2025-04-25 | $1.91 | $25K | +18.8% | -7.2% | +3.6% |
| BCDA | BUY | 2022-10-10 | 2022-10-11 | $2.07 | $4K | -1.9% | -11.4% | +9.0% |
| BCDA | BUY | 2018-11-05 | 2018-11-07 | $2.56 | $4K | -9.5% | -4.6% | -4.6% |
| BCDA | BUY | 2018-10-12 | 2018-10-16 | $2.64 | $1K | -9.5% | -4.6% | -4.6% |
| BCDA | BUY | 2018-09-25 | 2018-09-25 | $2.45 | $7K | -9.5% | -4.6% | -4.6% |
| BCDA | BUY | 2018-03-22 | 2018-03-22 | $1.90 | $950 | -9.5% | -4.6% | -4.6% |
| BCDA | BUY | 2018-03-21 | 2018-03-22 | $1.90 | $1K | -9.5% | -4.6% | -4.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.